Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

August 21, 2018August 21, 2018

NIH Awards $4 Million for Research on Inhaled Corticosteroids for SCD

News

The National Institutes of Health (NIH) has awarded $4 million to the departments of emergency medicine and hematology at the Icahn School of Medicine at Mount Sinai Hospital in New York ... Read more

May 22, 2018May 22, 2018

Sickle Cell Trait Not Associated with Increased Stroke Risk, Study Suggests

News

Sickle cell trait (SCT) is not associated with an increased incidence of stroke, a study in African-American patients suggests. The study, “Association of Sickle Cell Trait With Ischemic Stroke ... Read more

November 9, 2017November 9, 2017

Alzheimer’s Treatment Memantine Shows Promise in Treating Sickle Cell Disease

News

Memantine, a standard treatment for Alzheimer’s disease, has shown promise in treating sickle cell disease (SCD) in six patients, a 12-month pilot clinical trial found. The findings were presented ... Read more

September 28, 2017September 28, 2017

Phase 1 Trial Shows Imara’s Potential Therapy Safe for Treatment of Sickle Cell Disease

News

A Phase 1 clinical trial of Imara’s new investigational drug, IMR-687, showed that it was safe and well-tolerated in healthy volunteers, paving the way for a Phase 2 trial ... Read more

September 21, 2017September 21, 2017

PCORI Awards $18 Million to 2 Projects Helping Patients Transition to Adult Care

News

Over $18 million has been given to support research into how best to assist young people with sickle cell disease (SCD) moving from pediatric to adult care. The award comes from ... Read more

June 8, 2017June 8, 2017

Only 21% of Kids with ADHD and SCD Are Treated for Attention Deficit

News

A study of children with sickle cell disease (SCD) referred for an evaluation of neuropsychological deficits found that while 19 of 89 patients (25%) were diagnosed with attention deficit ... Read more

March 21, 2017March 21, 2017

Young Sickle Cell Patients Who Don’t Take Medication Have Lower Quality of Life

News

Adolescents and young adults with sickle cell disease (SCD) who don’t regularly take the medication hydroxyurea (or who don’t adhere to prescribed instructions) are generally those with medication-taking barriers such as forgetfulness, ... Read more

Pin It on Pinterest